|
QuintilesIMS Real-World Insights Bibliography
| A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom. |
| Author(s): Johnston RL1,2, Carius HJ3, Skelly A4, Ferreira A5, Milnes F4, Mitchell P6. |
| Affiliations(s): 1 The Royal College of Ophthalmologists' National Ophthalmology Database, London, UK.
2 Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
3 QuintilesIMS, Frankfurt am Main, Germany.
4 Novartis Pharma AG, Basel, Switzerland.
5 Novartis Pharma AG, Basel, Switzerland. alberto.ferreira@novartis.com.
6 Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Westmead, NSW, Australia.
|
| Publication(s): Advances in therapy |
| Document Type(s): Article |
| Countries: Australia, UK |
| Click here for the abstract |
C: Y: |
Ophthalmology 2017 |
|
L: A: |
English Retrospective cohort analysis |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C: Y: |
Oncology 2016 |
|
L: A: |
English Literature Review |
|
|
| |
| |
| Drug Utilization Study for Lisdexamfetamine Dimesylate (LDX) in Australia |
| Author(s): von Bredow D1, Ehlken B1, Blumentals WA2, Kolb N1, Keja J1, Maxwell T2 |
| Affiliations(s): 1 IMS HealthGmbH & Co. OHG, Munich, Germany, 1 Shire Pharmaceuticals, Lexington, MA, USA |
| Publication(s): 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) |
| Document Type(s): |
| Countries: Australia |
C: Y: |
Drug Utlization Study 2016 |
|
L: A: |
English Database Study, Survey research |
|
|
| |
| |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand |
C: Y: |
Ophthalmology 2012 |
|
L: A: |
English Burden of illness |
|
|
| |
| |
| Health economics review of bowel cancer in Australia |
| Author(s): Bishop J, Glass P, Tracey E, Hardy M, Warner K, Makino K, Gordois A, Wilson J, Guarnieri C, Feng J, Sartori L |
| Affiliations(s): |
| Publication(s): NSW Cancer Institute, Sydney |
| Document Type(s): Review |
| Countries: Australia |
C: Y: |
Health economics 2008 |
|
L: A: |
English Cost effectiveness |
|
|
| |
| |
| Remote monitoring systems for patients with implanted cardiac devices |
| Author(s): Medical Services Advisory Committee (MSAC), Australian Government Department of Health and Ageing. |
| Affiliations(s): |
| Publication(s): Department of Health and Ageing, Canberra: Australia |
| Document Type(s): Report |
| Countries: Australia |
C: Y: |
Cardiovascular disease 2008 |
|
L: A: |
English Review |
|
|
| |
| |
| Endobronchial ultrasound-guided procedures |
| Author(s): Medical Services Advisory Committee (assessors, Pricing and Market Access, Sydney) |
| Affiliations(s): |
| Publication(s): Published by the Commonwealth of Australia |
| Document Type(s): Review |
| Countries: Australia |
C: Y: |
Clinical practice 2008 |
|
L: A: |
English Review |
|
|
| |
| |
| Cost-effectiveness analysis of smoking cessation pharmacotherapies in Australia |
| Author(s): Bhatti T, Makino K, Guarnieri C, Gordois A, Cotter T, Perez D, Bishop J, Glass P |
| Affiliations(s): |
| Publication(s): ISPOR 3rd Asia-Pacific Conference, Seoul, Korea, September 2008 |
| Document Type(s): Poster |
| Countries: Australia |
C: Y: |
Health economics 2008 |
|
L: A: |
English Cost effectiveness |
|
|
| |
| |
| Pharmacotherapy evaluation: Drugs that assist smoking cessation |
| Author(s): Perez D, Cotter T, Makino K, Bhatti T, Gordois A, Guarnieri C, Lewis S, Glass P, Bishop J |
| Affiliations(s): |
| Publication(s): Sydney: Cancer Institute NSW |
| Document Type(s): Report |
| Countries: Australia |
C: Y: |
Health economics 2008 |
|
L: A: |
English Economic evaluation |
|
|
| |
| |
| Hepatitis B virus DNA testing |
| Author(s): Medical Services Advisory Committee (assessors Pricing and Market Access, Sydney Australia) |
| Affiliations(s): |
| Publication(s): Commonwealth of Australia |
| Document Type(s): Review |
| Countries: Australia |
C: Y: |
Infectious disease 2008 |
|
L: A: |
English Review |
|
|
| |
| |
1 of 4
|
|